2011
DOI: 10.1055/s-0031-1282034
|View full text |Cite
|
Sign up to set email alerts
|

Incidentally Detected Splenic Lesions in Ultrasound: Does Contrast-Enhanced Ultrasonography Improve the Differentiation of Benign Hemangioma/Hamartoma from Malignant Lesions?

Abstract: Sulfur hexafluoride-enhanced CEUS improves differentiation between benign vascular and malignant splenic tumors and may be especially useful in clinical scenarios in which the incidental hypoechoic splenic lesion is unclear on conventional US.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
40
0
10

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(51 citation statements)
references
References 13 publications
1
40
0
10
Order By: Relevance
“…In the arterial phase, benign lesions show iso-hyper-enhancement followed in the parenchymal phase by slow, modest and incomplete washout in only 31 % of cases. The great intensity of enhancement in the arterial phase in benign splenic pathologies may reflect hypervascularity caused by an increased arterial blood flow, while modest washout might be due to the presence of spleen-like sinusoidal epithelium [31]. In the arterial phase, malignant focal splenic lesions present inhomogeneous enhancement which may be poor and in some cases peripheral or absent with areas of hypo-enhancement associated with a rapid and complete washout, indicating a low uptake of contrast medium.…”
Section: Splenic Lymphomamentioning
confidence: 99%
See 2 more Smart Citations
“…In the arterial phase, benign lesions show iso-hyper-enhancement followed in the parenchymal phase by slow, modest and incomplete washout in only 31 % of cases. The great intensity of enhancement in the arterial phase in benign splenic pathologies may reflect hypervascularity caused by an increased arterial blood flow, while modest washout might be due to the presence of spleen-like sinusoidal epithelium [31]. In the arterial phase, malignant focal splenic lesions present inhomogeneous enhancement which may be poor and in some cases peripheral or absent with areas of hypo-enhancement associated with a rapid and complete washout, indicating a low uptake of contrast medium.…”
Section: Splenic Lymphomamentioning
confidence: 99%
“…A lesion which is constantly non-enhanced or isoenhanced in the parenchymal phase is to be considered benign in 100 % of cases, whereas a lesion showing progressive hypo-enhancement is predictive of malignancy in 87 % of cases [31].…”
Section: Splenic Lymphomamentioning
confidence: 99%
See 1 more Smart Citation
“…Hyperechoic FSLs incidentally detected on US are in most cases benign. CEUS improves the differentiation between benign and malignant FSLs especially for isoechoic or hypoechoic incidental lesions, unclear on conventional US [72]. Benign FSLs typically appear as nonenhancing in all phases (cystic lesions, infarcted areas) or show rapid enhancement followed by persistent late-phase enhancement (solid lesions).…”
Section: Spleenmentioning
confidence: 99%
“…Benign FSLs typically appear as nonenhancing in all phases (cystic lesions, infarcted areas) or show rapid enhancement followed by persistent late-phase enhancement (solid lesions). Malignant FSLs usually show early diffuse or peripheral enhancement, followed by "wash-out" in the late phase, with progressive hypo-enhancement [70,72,73]. In some cases the behaviour of malignant and benign lesions overlap, and benign lesions as haemangiomas, hamartomas, or other uncommon splenic abnormalities show some degree of "wash-out", mimicking a malignant pattern [70,74].…”
Section: Spleenmentioning
confidence: 99%